Vol. 143 No. 0102 (2013) | Swiss Medical Weekly (original) (raw)

Volume 143, No. 0102

Published January 1, 2013

Viewpoint

  1. Jürg H. Beer (Author)

Vitamin K antagonists are hard to beat by the price – are they? Some answers, new questions and the GPs’ dilemma

Review article: Biomedical intelligence

  1. Carol C. Hasler (Author)

Back pain during growth

  1. Christine Reinemann, Beate Strehlitz (Author)

Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment

Original article

  1. Angela Caduff Good, Daniel Nobel, Stephan Krähenbühl, Christof Geisen, Samuel Henz (Author)

Randomised trial of a clinical dosing algorithm to start anticoagulation with phenprocoumon

  1. Brigitte Landolt, Georg Staubli, Ulrich Lips, Lisa Weibel (Author)

Skin disorders encountered in a Swiss paediatric emergency department

  1. Claudia Praehauser, Renée Grandjean, Juerg Steiger, Michael Mayr (Author)

Cohort study on the quality of oral anticoagulation therapy in chronic haemodialysis patients treated with phenprocoumon

  1. Anne Chatton, Bengt Kayser (Author)
  1. Ekkehardt Altpeter, Hanspeter Zimmermann, Jürgen Oberreich, Olivier Péter, Charles Dvořák, Swiss Sentinel Surveillance Network (Author)
  1. David Conen, Tobias Schön, Stefanie Aeschbacher, Guillaume Paré, Walter Frehner, Martin Risch, Lorenz Risch (Author)

Genetic and phenotypic determinants of blood pressure and other cardiovascular risk factors

  1. Mark Pletscher, Rafael Plessow, Klaus Eichler, Simon Wieser (Author)

Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland

  1. Hua Wang, Yi He, Wen-jing Zhai, Mei Wang, Zheng Zhou, Ying-xin Zhao, Si-zhou Feng, Ming-zhe Han (Author)

The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor haematopoietic stem cell transplantation for myeloid malignancies

  1. Andreas Maercker, Axel Perkonigg, Martin Preisig, Karl Schaller, Michael Weller, Cost of Disorders of the Brain in Europe Study Group (Author)

The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010